FDA-Drug2026-07-01Class IIMISBRANDING
Major Pharmaceuticals Methylergonovine Maleate 0.2 mg tablets recalled for subpotency
LABEL MIX UPNationwide distribution
Major Pharmaceuticals Methylergonovine Maleate recalled for subpotency
MAJOR Pharmaceuticals is recalling Methylergonovine Maleate Tablets, USP, 0.2 mg due to subpotency — meaning the tablets contain less active ingredient than labeled. The affected lots were distributed nationwide. This is a prescription medication used to control bleeding after childbirth.
- If you have a prescription for this medication, contact your pharmacy or doctor immediately.
- Do not stop taking your medication without speaking to your doctor.
- Check the lot number on your bottle against the recall list: N02327 (expires 09/2026), N02740 (expires 12/2026), or N03069 (expires 08/2027).
Hazard
Subpotent Drug
Sold states
U.S. Nationwide.
Affected count
790 Cartons.
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0609-2026More The Harvard Drug Group LLC recalls
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief